People form the core of our success

Scientists and employees

leadXpro’s team of more than 20 experts originates from 13 different countries. Over 60% of our team members hold PhDs, combining diverse scientific backgrounds and a wealth of industry experience.

Board of Directors

Michael Hennig

CEO and chairman of the board
Structural biologist and senior drug discovery executive. Previously, global leader discovery technologies at Roche.

More

After his PhD at the EMBL Hamburg and a postdoc at the Biozentrum of the University of Basel Michael Hennig looks back to 20 years of drug discovery expertise in structural biology and research management at F. Hoffmann – La Roche AG Basel. Helped deliver Tamiflu, Fortovase, Xenical, Carmegliptin, Aleglitazar and is author of more than 70 articles and 8 patents. He holds a professorship position for structural biology at the University of Basel.

Rafael Abela

Board of Directors
Physicist at the PSI, scientific project leader for the SLS and SwissFEL projects.

Juana L. Flores-Candia

Board of Directors
Global leader in Innovation & Business Strategy. Pursued scientific discoveries and built businesses in seven countries and four continents while working for Roche, Novartis, and GSK.

More

Juana holds a PhD from the TU of Braunschweig in Germany, a Master in Biotech from the U. of Kent at Canterbury (UK), and an MBA from IMD in Switzerland. She is passionate about applying science and cutting-edge technologies to make a positive difference in the lives of people. Named as inventor in 22 patents, published a book on Metabolic Flux Modelling and co-authored the Encyclopedia of Bioprocess Technology (John Wiley & Sons, Inc). Built new market segments, accelerated innovation pipelines, designed and delivered brand strategies resulting in business turnarounds and double-digit growths while working for Roche, DSM, Novartis, and GSK.

Martin Jermann

Board of Directors
Physicist, several management positions at the PSI including acting director function. Head of PSI proton therapy development program.

Andreas Insam

Board of Directors
Doctor in political economics, University of Innsbruck. Previously CEO of Bendura Bank, previously Board member of LGT Bank.

More

Dr. Insam holds the qualification Dr. rer. soc. oec. from the University of Innsbruck. He was CEO of BENDURA BANK AG since it was founded in 1998 until his retirement in 2020. He was a long-standing member of the Board of Managers of LGT Bank in Liechtenstein (Frankfurt) GmbH, responsible for the Institutional Sales division. After he obtained his doctorate in Business Administration, he served as Research Assistant at the University of Innsbruck’s Institute of Mathematics and Statistics, and later became Assistant to the Executive Board of LGT Bank in Liechtenstein. Andreas Insam has been a lecturer and examiner at the University of Liechtenstein for many years.

Scientific Advisory Board

Gebhard Schertler

Expert, Membrane Protein Science
Biochemist, department head BIO and member of the Directorial Board of the Paul Scherrer Institute PSI.

Henning Stahlberg

Expert, Electron Microscopy
Structural biologist and professor for Physics at the EPFL Lausanne. Director of the Dubochet Center for Imaging.

More

Henning studied physics at TU Berlin, Germany, PhD in structural biology at the EPFL Lausanne, Switzerland, post-doc and habilitation in biophysics at the Biozentrum, University of Basel, Switzerland on transmission electron microscopy of proteins and protein complexes.

He was professor for molecular & cellular biology at UC Davis, USA, from 2003-2010, and was heading the Center for Cellular Imaging and NanoAnalytics (https://c-cina.org) at the Biozentrum of the University of Basel from 2009-2020.

Since 2020, he is professor of Physics at the EPFL Lausanne (https://www.epfl.ch/labs/lbem/), where he sets up and directs the Dubochet Center for Imaging. Author of more than 192 peer reviewed papers.

Bernd Kuhn

Expert, Computational Chemistry
Ph.D. in Physical Chemistry from EPF Lausanne, post-doc at UCSF, scientist at Prospect Genomics start-up, 15 years at Roche.

Career opportunities at leadXpro

Contact

leadXpro AG
PARK InnovAARE
CH-5234 Villigen
Switzerland

info@leadxpro.com